Inspire Medical Systems Stock Price, News & Analysis (NYSE:INSP) $145.43 +0.12 (+0.08%) (As of 10:47 AM ET) Add Compare Share Share Today's Range$143.29▼$145.9650-Day Range$125.26▼$200.6152-Week Range$123.27▼$330.00Volume34,056 shsAverage Volume491,516 shsMarket Capitalization$4.29 billionP/E RatioN/ADividend YieldN/APrice Target$283.92 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Inspire Medical Systems MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.85 Rating ScoreUpside/Downside95.4% Upside$283.92 Price TargetShort InterestHealthy4.47% of Shares Sold ShortDividend StrengthN/ASustainability-0.66Upright™ Environmental ScoreNews Sentiment0.40Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.48) to ($0.70) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.59 out of 5 starsMedical Sector154th out of 948 stocksSurgical & Medical Instruments Industry23rd out of 97 stocks 4.4 Analyst's Opinion Consensus RatingInspire Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.85, and is based on 11 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $283.92, Inspire Medical Systems has a forecasted upside of 95.4% from its current price of $145.33.Amount of Analyst CoverageInspire Medical Systems has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.47% of the outstanding shares of Inspire Medical Systems have been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 10.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. Previous Next 4.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreInspire Medical Systems has received a 78.27% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is false driven by its "Neurostimulators" and "Medical technology engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Inspire Medical Systems is -0.66. Previous Next 1.9 News and Social Media Coverage News SentimentInspire Medical Systems has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Inspire Medical Systems this week, compared to 5 articles on an average week.Search InterestOnly 13 people have searched for INSP on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows7 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.50% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Inspire Medical Systems are expected to grow in the coming year, from ($1.48) to ($0.70) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is -128.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is -128.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 7.89. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Inspire Medical Systems Stock (NYSE:INSP)Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.Read More INSP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INSP Stock News HeadlinesNovember 30, 2023 | finance.yahoo.com3 Reasons to Retain Inspire Medical (INSP) Stock for NowNovember 17, 2023 | seekingalpha.comInspire Medical Systems: Time To Wake UpDecember 1, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 14, 2023 | finance.yahoo.comFMR LLC Bolsters Portfolio with Inspire Medical Systems Inc AcquisitionNovember 14, 2023 | finance.yahoo.comInspire Medical Systems, Inc. to Present at the Piper Sandler 35th Annual Healthcare ConferenceNovember 11, 2023 | finance.yahoo.comInspire Medical Systems (INSP) Fell on Fears Relating to Increasing Adoption of Weight Loss DrugsNovember 9, 2023 | msn.comBeacon Health System holds career day at Washington High SchoolNovember 8, 2023 | finance.yahoo.comInspire Medical Systems, Inc. (NYSE:INSP) Q3 2023 Earnings Call TranscriptDecember 1, 2023 | Wealthpress (Ad)Trading Experts Call It “The Perfect Tesla Trade”Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.November 8, 2023 | markets.businessinsider.comInspire Medical's Recovery from Temporary Q3 Revenue Shortfall - Analysts Find OptimismNovember 8, 2023 | marketwatch.comInspire Medical Shares Slip Premarket After Revenue MissNovember 8, 2023 | finance.yahoo.comThe 9.9% return this week takes Inspire Medical Systems' (NYSE:INSP) shareholders five-year gains to 250%November 8, 2023 | finance.yahoo.comLifeLens Technologies Expands Executive Leadership Team and Board of DirectorsNovember 7, 2023 | markets.businessinsider.com6 Analysts Have This to Say About Inspire Medical SystemsNovember 7, 2023 | finance.yahoo.comInspire Medical Systems, Inc. Announces Third Quarter 2023 Financial Results and Updates 2023 OutlookNovember 7, 2023 | seekingalpha.comInspire Medical Systems, Inc. 2023 Q3 - Results - Earnings Call PresentationNovember 1, 2023 | finance.yahoo.comInspire Medical Systems, Inc. to Present at the Stifel 2023 Healthcare ConferenceOctober 25, 2023 | msn.comInspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales GrowthOctober 23, 2023 | finance.yahoo.comNeuros Medical, Inc. Names David Veino as President and CEO and Expands Board of DirectorsOctober 19, 2023 | finance.yahoo.comHere’s Why Inspire Medical Systems (INSP) Declined in Q3October 18, 2023 | msn.comJP Morgan Maintains Inspire Medical Systems (INSP) Overweight RecommendationOctober 17, 2023 | msn.comLeerink Partners Initiates Coverage of Inspire Medical Systems (INSP) with Market Perform RecommendationOctober 17, 2023 | finance.yahoo.comMedTech Earnings in the Age of Ozempic May Not Be That BadOctober 12, 2023 | finance.yahoo.comOctane's Medical Innovation Forum Set to Inspire Transformation in HealthcareOctober 12, 2023 | finance.yahoo.comEstimating The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)October 11, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Silk Road Medical (SILK), Viracta Therapeutics (VIRX)October 11, 2023 | finance.yahoo.comUnveiling Inspire Medical Systems (INSP)'s Value: Is It Really Priced Right? A Comprehensive GuideSee More Headlines Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/07/2023Today12/01/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNYSE:INSP CUSIPN/A CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees755Year FoundedN/APrice Target and Rating Average Stock Price Target$283.92 High Stock Price Target$371.00 Low Stock Price Target$159.00 Potential Upside/Downside+95.2%Consensus RatingModerate Buy Rating Score (0-4)2.85 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)($1.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-44,880,000.00 Net Margins-5.75% Pretax Margin-5.59% Return on Equity-6.32% Return on Assets-5.47% Debt Debt-to-Equity RatioN/A Current Ratio8.14 Quick Ratio7.76 Sales & Book Value Annual Sales$407.86 million Price / Sales10.53 Cash FlowN/A Price / Cash FlowN/A Book Value$18.43 per share Price / Book7.89Miscellaneous Outstanding Shares29,520,000Free Float28,195,000Market Cap$4.29 billion OptionableOptionable Beta1.48 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Timothy P. Herbert (Age 60)CEO, President & Director Comp: $1.35MMr. Philip J. Ebeling (Age 52)Chief Operating Officer Comp: $696.13kMr. John C. Rondoni (Age 43)Chief Technology Officer Comp: $576.72kMr. Randall A. Ban (Age 58)Chief Commercial Officer Comp: $759.23kDr. Charisse Y. Sparks FAAOS (Age 60)M.D., Chief Medical Officer Comp: $21.88kMs. Ezgi YagciVice President of Investor RelationsMr. Bryan K. Phillips (Age 52)Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary Comp: $639.9kMr. Martin A. AbramsVice President of Marketing & Customer ExperienceMr. Steven L. Jandrich (Age 56)Vice President of Human Resources Comp: $417.22kMr. Ivan LubogoSenior Vice President of U.S. SalesMore ExecutivesKey CompetitorsImmunoGenNASDAQ:IMGNBlueprint MedicinesNASDAQ:BPMCHaemoneticsNYSE:HAEPerrigoNYSE:PRGOMerit Medical SystemsNASDAQ:MMSIView All CompetitorsInsiders & InstitutionsAmerican Century Companies Inc.Bought 45,322 shares on 11/30/2023Ownership: 0.170%Deutsche Bank AGSold 925 shares on 11/24/2023Ownership: 0.020%Polar Capital Holdings PlcSold 262,492 shares on 11/22/2023Ownership: 0.009%Graham Capital Management L.P.Bought 1,256 shares on 11/22/2023Ownership: 0.004%Walleye Trading LLCSold 11,300 shares on 11/21/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions INSP Stock Analysis - Frequently Asked Questions Should I buy or sell Inspire Medical Systems stock right now? 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" INSP shares. View INSP analyst ratings or view top-rated stocks. What is Inspire Medical Systems' stock price target for 2024? 13 Wall Street analysts have issued 1 year price objectives for Inspire Medical Systems' shares. Their INSP share price targets range from $159.00 to $371.00. On average, they expect the company's share price to reach $283.92 in the next year. This suggests a possible upside of 95.4% from the stock's current price. View analysts price targets for INSP or view top-rated stocks among Wall Street analysts. How have INSP shares performed in 2023? Inspire Medical Systems' stock was trading at $251.88 at the start of the year. Since then, INSP shares have decreased by 42.3% and is now trading at $145.33. View the best growth stocks for 2023 here. Are investors shorting Inspire Medical Systems? Inspire Medical Systems saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,320,000 shares, an increase of 10.0% from the October 31st total of 1,200,000 shares. Based on an average daily volume of 730,800 shares, the days-to-cover ratio is currently 1.8 days. View Inspire Medical Systems' Short Interest. When is Inspire Medical Systems' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 6th 2024. View our INSP earnings forecast. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.53) by $0.24. The company earned $153.30 million during the quarter, compared to the consensus estimate of $154.49 million. Inspire Medical Systems had a negative net margin of 5.75% and a negative trailing twelve-month return on equity of 6.32%. The business's quarterly revenue was up 40.4% compared to the same quarter last year. During the same quarter last year, the business posted ($0.60) earnings per share. What ETFs hold Inspire Medical Systems' stock? ETFs with the largest weight of Inspire Medical Systems (NYSE:INSP) stock in their portfolio include Harbor Health Care ETF (MEDI), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Fidelity Digital Health ETF (FDHT), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), BNY Mellon Innovators ETF (BKIV), Principal Healthcare Innovators ETF (BTEC), Franklin Intelligent Machines ETF (IQM) and WisdomTree U.S. Growth & Momentum Fund (WGRO). What is Tim Herbert's approval rating as Inspire Medical Systems' CEO? 2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). When did Inspire Medical Systems IPO? (INSP) raised $75 million in an IPO on Thursday, May 3rd 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. Who are Inspire Medical Systems' major shareholders? Inspire Medical Systems' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include FMR LLC (8.37%), Westfield Capital Management Co. LP (2.48%), William Blair Investment Management LLC (2.37%), Federated Hermes Inc. (1.68%), Fred Alger Management LLC (1.37%) and Bank of New York Mellon Corp (1.27%). Insiders that own company stock include Georgia Melenikiotou, Jerry C Griffin, John Rondoni, Marilyn C Nelson, Philip Ebeling, Randy Ban, Richard Buchholz, Steven Jandrich and Timothy P Herbert. View institutional ownership trends. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NYSE:INSP) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.